Company profile: Calyx
1.1 - Company Overview
Company description
- Provider of medical imaging, eClinical, and regulatory solutions and services to solve complex challenges in clinical research.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Calyx
Nanosyn
HQ: United States
Website
- Description: Provider of integrated drug discovery services as a contract research organization, including medicinal chemistry, made-to-order focused compound libraries, hit-to-lead optimization, process chemistry, analytical, and screening and profiling services for drug discovery needs; specializing in design, synthesis, and analysis of small organic.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanosyn company profile →
Multi-Specialty Research Associates
HQ: United States
Website
- Description: Provider of Phase I-IV clinical trial services across a wide range of therapeutic areas, including vaccine research for Covid-19 and other infectious diseases, delivered from its north Florida office and backed by more than 50 years of combined research experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multi-Specialty Research Associates company profile →
Multisorb
HQ: United States
Website
- Description: Provider of active packaging technology and sorbent solutions that protect products from moisture, oxygen, and volatiles, including desiccants, oxygen absorbers, and volatile/odor control. Offers SimulSorb and SimulOx simulation programs to predict pharmaceutical stability, APA series dispensing equipment to streamline production, and R&D services for tailored active packaging systems, testing, and evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multisorb company profile →
Novasep
HQ: France
Website
- Description: Provider of contract development and manufacturing services for active pharmaceutical ingredients (APIs) and biopharmaceuticals, covering process development, scale-up and commercial cGMP production. Offers lipid synthesis and purification (including lipid nanoparticles for RNA therapies), industrial chromatography for API/biomolecule purification, specialized steroid and high-potent API manufacturing, and small-molecule API production including custom development for large-volume molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novasep company profile →
Yposkesi
HQ: France
Website
- Description: Provider of CDMO services for gene and cell therapy, including cGMP manufacturing of AAV and lentiviral vectors (clinical and commercial batches), upstream and downstream bioprocess development, analytical development with assay qualification and validation, cGMP fill & finish, regulatory support, and the LentiSure platform to optimize yields, productivity, and transduction efficiency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Yposkesi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Calyx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Calyx
2.2 - Growth funds investing in similar companies to Calyx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Calyx
4.2 - Public trading comparable groups for Calyx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →